Table 1. Characteristics of the study population.

Donor
Gender (M/F)	141/298
Age (yr)	50.2±8.1
Weight (Kg)	59.4±8.9
Recipient
Gender (M/F)	325/114
Age (yr)	32.0±8.5
Weight (Kg)	58.4±10.4
HD/PD/No dialysis	326/73/40
Duration of dialysis (M)	5.0(3.0,12.0)
Maintenance immunosuppression
FK506/ CsA +MMF + pred	395/44
HLA-mismatch	2.62±1.29
Warm ischemia time (min)	2.89±0.71
Cold ischemia time (min)	123.65±68.92
—Weight ratio of Donor-Recipient	1.04±0.24
Cause of ESRD
Glomerulonephritis	366 (88.37%)
IgA nephropathy	32 (7.29%)
Polycystic kidney disease	5 (1.14%)
Anaphylactic purpura nephritis	5 (1.14%)
Alport syndrome	4 (0.91%)
Lupus	3 (0.68%)
Others/unknown	24 (5.47%)

HD: hemodialysis; PD: peritoneal dialysis; FK-506: tacrolimus; CsA: cyclosporin A; MMF: mycophenolatemofetil; ESRD: end-stage of renal disease.